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Vascular perfusion and hypoxic areas in RIF-1 tumours after photodynamic 
therapy
IPJ van Geel1, H Oppelaar1, PFJW Rijken2, HJJA Bernsen2, NEM Hagemeier2, 
AJ van der Kogel2, RJ Hodgkiss-1 and FA Stewart1
1 Division o f  Experimentell Therapy, The Netherhmds Cancer Institute/Antoni van Leemvenhoekiuds> Amsterdam; 3Institute o f  
Radiotherap)■, Univei\svly o j ' Nijmegen, The Neiher!and's; 3Gray Laboi\itory, London, UK.
Summary The influence o f  photodynamic therapy (PDT) on vascular perfusion and the development of 
hypoxia was investigated in the murine RIF-1 tumour. Image analysis was used to quantify changes in 
perfusion and hypoxia at 5 nun after interstitial Photofrin-mediated PDT. The fluorescent stain Hoechst 33342 
was used as an in vivo marker o f  functional vascular perfusion and the antibody anti-collagen type IV as a 
marker of the tumour vasculature. The percentage of total tumour vasculature that was perfused decreased to 
less than 30% of control values after PDT. For the lower light doses this decrease was more pronouuccd in the 
centre or the tumour. The observed reduction in vascular perfusion showed a good linear correlation (r -0 .9 8 )  
with previously published tumour perfusion data obtained with the Ki,Rb extraction technique. The image 
analysis technique provides extra information concerning the localisation of (non)-perfused vessels. To detect 
hypoxic tumour areas in vivo, an imiminohistochemical method was used employing NITP [7-(4'~(2- 
nitroi mid azoM-yI)-butyl)-theophylline], A large increase in hypoxic areas was found for PDT-treated tumours. 
More than half the total tumour area was hypoxic after PDT, compared with <4%  for control tumours. Our 
studies illustrate the potential o f  image analysis systems for monitoring the functional consequences of PDT- 
niedialed vascular damage early after treatment. This provides direct confirmation that the perfusion changes 
lead to tissue hypoxia, which has implications for the combined treatment of PDT with bioreductive drugs.
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The three-dimensional growth o f  solid tum ours  requires a 
vascular network of new capillaries. These new capillaries 
lack a supporting architecture and are thin-walled and leaky. 
The lack o f  a smooth muscle wall also renders them less 
responsive to vasoactive stimuli and more prone to 
compression, especially in larger tumours in which the 
interstitial pressure is raised, Thus, a tum our often has 
oxygen diffusion gradients and  a relatively poor  nutrient 
supply, which may result in areas o f  necrosis (Trotter et al 
1989; Vaupel et al., 1989; Folkm an, 1993). There is a close 
relationship between the width o f  the viable cell rim around 
the vessels and the distance tha t  oxygen diffuses through the 
tumour. In certain tum our types, small areas o f  necrosis are 
seen between the blood vessels, i.e. a corded tum our structure 
(Thom 1 in son and Gray, 1955). Central necrosis is also a 
common feature of larger tumours. Cells under extremely low 
p 0 2 values are likely to exist close to the areas o f  necrosis. 
These areas o f  chronic hypoxia are the result o f  oxygen 
diffusion limitations. Transient, acute hypoxia has also been 
demonstrated in tumours (Trotter  et al,, 1989). This is a 
perfusion-limited lypoxia that is caused by a temporary 
interruption of blood (low within the vasculature as the 
vessels undergo spontaneous opening and closing. Both 
chronic and acute mechanisms are responsible for the 
presence of hypoxic cells in tumours (Chaplin et al., 1987).
The percentage o f  hypoxic cells in a tum our may alter 
during therapy as previously hypoxic cells reoxygenate o r  
new areas become hypoxic. Simple, rapid tests for the 
presence o f  hypoxic cells in tum ours  (e.g. Hirsch et a I 
1987; Hodgkiss et a l 1991) could enable therapies like 
radiotherapy and photodynam ic  therapy (PDT) to be 
optimised on the basis o f  the oxygen status o f  the tumours. 
The hypoxic m arker N IT P  [7-(4'-(2-nitroimidazol-l-yl)-butyl)-
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theophylline] (Hodgkiss et a l 1991) detects the presence o f  
severely hypoxic cells, since nitroimidazoles are reduced in 
vitro at low oxygen levels, with K  values of 0,02 -0.2% 
oxygen (oxygen level required for half-maximum sensitivity) 
depending on cell line and compound (Taylor and Rautli, 
1982; Mulcahy, 1984; Hodgkiss et al., 1991). Hypoxia 
represents a potential disadvantage to tum our cell killing by 
PDT, since fully hypoxic cells are completely resistant to this 
treatment; K  values of 0 .5 -  1% oxygen have been determined 
for PDT cell killing in vitro (Henderson and Fingar, 1987; 
Chapman et a l 1991«), Consequently even if all the 
oxygenated cells of a tumour are killed by PDT, a hypoxic 
subpopulation could survive and allow the tum our to regrow. 
Severe PDT-induoed vascular damage, which results in 
oxygen and nutrient deprivation, does, however, lead to 
secondary tumour cell death of these hypoxic 
(Henderson et a 1985). An understanding of the oxygen 
status of the tumour before and after P D T  is very important 
for optimising treatment schedules, particularly if PDT is to 
be combined with bioreductive drugs, Intervention with 
bioreductive drugs could potentially increase the killing of 
naturally occurring hypoxic tum our cells or cells rendered 
hypoxic by PD T (Gonzalez et al,, 1986; Bremner et a l 1992; 
Baas et al., 1994). Hypoxia can occur even before the 
development of PDT-induced vascular damage. The photo­
chemical processes involved in PD T  consume oxygen very 
rapidly and oxygen depletion can occur during continuous 
illumination, particularly at high flue nee rates (Foster et al.,
1991).
The purpose of this study was to analyse the patterns of 
vascularisation and hypoxic areas simultaneously in the RIF-
1 tumour before and after PD T  and to examine the influence 
of PDT on vascular perfusion and oxygen status in the 
tumour. The morphology o f  the vasculature was visualised 
with an antibody directed against the basal lamina of the 
blood vessels and areas of functional perfusion were 
identified with Hoechst 33342. For identifying the hypoxic 
areas in the tumour, the immunologically detectable 
hapten theophylline was used, covalently bound to a 2- 
nitroimidazole (NITP).
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Materials and methods
Animal models
All experiments were carried out in accordance with 
protocols approved by the local experimental animal welfare 
committee and conformed to national and European 
regulations for animal experimentation. Female C.TH/Km 
mice were used, weighing 2 1 -3 0  g at an age of 11 -  16 weeks. 
Approximately 1 x 10s RIF-1 cells [maintained and  passaged 
according to recommended in vivo ¡in vitro protocols described 
by Twentyman et aL (1980)] were inoculated subcutaneously 
on the lower dorsum of mice, which were hr icily 
anaesthetised with enilurane, Tum our growth was docum en­
ted three times per week by calliper measurements in three 
orthogonal diameters. PDT treatment was given 11 -  15 days 
(mean 12.2 ± 0 .4  s.e.) after inoculation, when the turn our had  
reached a mean diameter o f  5 6 mm. T he  tumours were free 
of evident necrosis at these sizes.
Interstitial photoclynaniic therapy o f  tumours
The mice were injected i.p. with Photofrin  (supplied by 
Quadra Logic Technologies, Vancouver, Canada). Photofrin  
was dissolved in 5% dextrose at a concentration o f
2 mg ml ' 1 (for a dose of 10 mg k g 1). The photosensitiser 
was injected 1 day before illumination. This time interval was 
based on previous studies to establish times o f  m axim um  
drug uptake and photosensitisation (van Geel et aL , 1995a).
The light source was a dye laser (Spectra Physics model 
373) pumped by a 12 W argon laser (Spectra Physics model 
171). DCM  [(4-dicyanomethylene)~2-methyl'6-(/?-dimethami- 
no)-4H-pyrane: Radient Dyes Chemie, Wermelkirchen, 
Germany] was used as the dye to obtain red laser light o f  
628 +  3 nm (mono Chrom ator Oriel model 77320). The light 
was directed to a beam splitter that divided the light equally 
among four outputs, to which non-scintillating polystyrene 
fibres (Bicron BCF, 1 mm outer diameter) with 1 cm 
cylindrical diffusing tips were attached. The o u tp u t  from 
each fibre was adjusted to 100 mW cm 1 and energies of 30 
200 J cm 1 were delivered by varying the exposure lime from 
5 to 34 min. The did using fibres were inserted through the 
centre of the tumours o f  unanaesthetised mice held in
restraining jigs, as described by Baas et al. (1993). Mice 
were kept in subdued light after receiving the photosensitiser.
w,RhCI extract ion o f  estimates o f  vascular perfusion
Vascular perfusion relative to the cardiac o u tp u t  was 
measured using the w,RbCl extraction technique as described 
previously (van Geel et 1994). These results have been 
previously reported but are included here for com parison 
with the image analysis estimates of perfusion.
Staining o f  perfused vessels
The perfusion marker Hoechst 33342 (Aldrich, Milwaukee, 
WI, USA) was dissolved in sterile saline immediately before 
use. Mice were injected i.v. via one of the lateral tail veins 
with 0.1 ml Hoechst (at a concentration o f  9 mg ml ') 5 min 
after illumination. Mice were killed by cervical dislocation 
I min after injection to prevent diffusion o f  Hoechst 33342 
into adjacent non-perfused vascular structures. Thus, Hoechst 
specifically labels the nuclei o f  endothelial cells and nuclei o f  
the cells adjacent to the vessel walls, thereby delineating the 
perfused vessels. The tumours were excised and frozen in 
liquid nitrogen before storing at ~ 7 0 "C  until they were 
sectioned. Frozen sections were taken from three levels 
(periphery, centre and contralateral periphery; three sections 
each) of each tumour.
As a marker of the basal lamina o f  the tum our  
microvasculature, an antibody against the basal lamina 
component collagen IV was used (rabbit polyclonal an tibody 
against collagen type IV, Eurodiagnostics BV, Oss, The 
Netherlands) as described by Bernsen et aL (1995). Briefly, 
sections were air dried and lixed in acetone for 10 min.
Subsequently they were washed in phospliate-buHerod saline 
(PBS) for 10 min. Sections were incubated with the antibody 
to collagen IV (1 :50  dilution in PBS containing 10% normal 
goat serum) for 45 min. After washing in PBS, the second 
antibody (goat anti-nib bit T R IT C  conjugated: Tago, 
Burlingame, USA) was applied at a dilution of 1:25 in 
PBS containing 10% normal goat serum. The vascular 
pa tte rn  o f  RIF-1 tumours was visualised with a fluorescence 
microscope (Axioshop, Zeiss) with 510 560 nm excitation 
and 590 nm emission filters showing red fluorescence. 
Hoechst 33342 could be studied under ultraviolet illumina­
tion showing blue fluorescence (excitation at 365 nm and 
emission at 420 nm) in the same sections.
Staining o f  hypoxic areas
The hypoxic m arker N ITP  (supplied by Dr Hodgkiss) was 
dissolved in peanut oil (Sigma, St Louis, MO, USA) 
containing 10% dimethyl sulphoxide (DMSO) and injected 
i.p. in a volume o f  0.27 ml for a 25 g mouse (0.5 mmol kg '). 
Animals were injected 30 min before illumination and killed 
by cervical dislocation 120 min after administration of the 
drug. At this time, imnuinohisloehcmioai detection of the 
bound theophylline groups in mouse tumours has been 
shown to be optimal (Hodgkiss ¿7 al.,, 1991). Previous results 
had dem onstrated  no significant difference in vascular 
perfusion determined (by 8(1 Rb extraction) at 5 min or 2 h 
after P D T  o f  RIF-1 tumours (van Geel et a l., 1994). Freshly 
excised tumours were frozen immediately in liquid nitrogen 
and stored a t — 70°C until they were sectioned. The method 
described by Hodgkiss et a I. (1991), with minor modifica­
tions, was used to stain hypoxic areas. Frozen sections were 
air dried and lixed in cold acetone. Non-specific sites were 
blocked with 0.5% normal goat serum in PBS. A rabbit anti- 
theophylline antibody (Sigma), diluted 1:2  in PBS, was 
applied and the sections incubated for 1 li. Pilot studies 
indicated that the best results were obtained with this 
dilution. After washing in PBS the sections were incubated 
for I h with a second biolinylated antibody (I: 100). 
Subsequently, avid in alkaline phosphatase (Sigma) was 
added and the sections were incubated for 45 min. After 
final washings with PBS the enzyme substrate (containing 
0.04% 4-nitro-blue tetrazolium chlorid ie-1-0.02% 5-bromu-4- 
chloro-3-indolyl phosphate-F 0.8% dimelhylformamide in 
0.1 mM Tris /H C l buffer pH 9.5 -1“ 50 n\M magnesium chlor­
ide f 0.1 m sodium chloride) was added, resulting in a red 
purple staining o f  the hypoxic areas (Coco Martin et uL ,
1992).
Image analysts
Whole tum our sections were automatically scanned using a 
digital image processing system to quantitate tumour vascular 
area and percentage of perfused vessels (after staining of 
sections for collagen and In vivo Hoechst injection respec­
tively). The digital imaging procedure is described in detail by 
Rijken et tiL (1995). Briefly, the tum our sections were scanned 
twice on the computer-controlled motorised stage (Marx- 
hau/.er, Wetzku\ Germany) o f  a fluorescence microscope 
(Zeiss, Oberkoehen, Germany), using two dilferent filters 
{Hoechst and T R IT C  detection) and an intensified solid stale 
camera (M XRi: HCS, Hind haven. The Netherlands). Major 
artifacts such as air bubbles and mechanically damaged areas 
were excluded from analysis. Each image was processed to 
delect the stained structures using the folk)wing processing 
operations: image reduction, shading correction, object 
isolation from I be background using a previously determined 
threshold. Per tum our section, new threshold values could be 
determined interactively before scanning the section if 
intensity differences between sections occurred. After proces­
sing all fields of each scan (field size; 1.22 m n r ,  10 x 
objective: digital imaging application TCL-image, TNO, 
Delft, The  Netherlands) the scanned area was reconstructed 
into one large image. This resulted in two composite images, 
one with vascular structures (as stained with TRITC; Figure
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sections), Hoechst 33342 was injected 150 min after NITP 
and the mice were sacrificed I min after Hoechst 33342 
injection. After staining for hypoxia, clear red purple areas 
were detected under the light microscope. The whole tumour 
sections were then scanned, using a charged-coupled device 
(CCD) camera (MX-5, HCS, Eindhoven, The Netherlands), a 
light microscope (Zeiss) and the same staged-coupled 
computer system with digitial imaging application as 
described earlier, for quantitative analysis of hypoxic areas. 
Again, the scanned area was reconstructed into one large 
image. The relative hypoxic area (RHA) was expressed as the 
total surface of the hypoxic areas divided by the total tumour 
surface. For illustration of the spatial relationship between 
hypoxic and perfused areas, the image of perfused vessels 
stained by Hoechst in adjacent tum our sections was merged 
with the image of hypoxic areas. The perfused vessels stained 
blue and hypoxic areas were given a pseudocolour green.
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Figure 1 Black and white illustrations o f  the combination o f  
composite images, obtained after scanning tumour sections o f  the 
RIF-1 tumour using a semi automated image analysis system, to 
analyse vasculature and perfused vessels in the same tumour 
section, (a) First scan o f  vasculature (stained with anti-collagen 
IV). (l>) Second scan o f perfused vessels (Hoechst). (c) Overlap o f  
(a) and (b) to indicate the vascular structures that were perfused.
la) and ano ther  with the perfused areas (Hoechst; Figure lb). 
The relative vascular area  (RVA) is defined as the total 
surface o f  all vascular structures divided by the total tum our 
area. When the two com posite  images were combined, the 
overlapping stained vessels represented the vasculature, which 
was perfused by Hoechst 33342 at the time of injection 
(Figure 1c). The  area o f  the overlapping vasculature divided 
by the total vascular area yielded the perfused fraction (PF) 
in this tum our section. T he  relative perfused tum our area 
(RPTA) was determined by dividing the perfused vascular 
area by the tu m ou r  area.
To com pare spatial d is tr ibution  of perfused vessels with 
measurement o f  hypoxic areas in the same tum our (adjacent
Statistical anali w/.y
*
The means and standard errors (s.e.) were calculated for three 
sections of each of the central and /o r  peripheral areas o f  each 
tumour (w —2 - 4 )  and used for further statistical analysis. 
The significance o f  difference in vascular parameters or the 
level of hypoxia for the control and treated groups was 
determined according to the Student’s /-test. Avalues <0.05 
were considered significant.
Results
Vascular p e r f  its ion
The mean relative vascular area (RVA) as determined by 
image analysis varied from 4 to 12% for control (untreated, 
Photofrin or light alone) and treated tumours (see Table I). 
Within the same tumour the mean RVA was generally fairly 
homogeneous through the central and peripheral part o f  the 
tumour (Figure 2a and b), although the periphery was 
slightly, but not significantly, better vascularised than the 
centre of the tumour after light alone. No significant 
difference was found between the mean RVA of the 
untreated control group and all the other groups (drug 
alone, light alone or PDT).
The mean relative perfused total area (RPTA) of untreated 
control tumours was 3 .0+  1.1%. There was a reduction after 
Photofrin or light alone (2 .2+ 0.3% and 1 .5 % + 0 .2 %  
respectively) which was most marked in central areas o f  
tumours treated with light alone, probably caused by fibre 
insertion (Table I). The MR b extraction technique (separate 
tumours) also demonstrated a small, but significant decrease 
in blood flow of tumours treated with fibre or light alone 
(van Geel et aL, 1994). PD T with 200 J c m “ 1 caused a further 
reduction in relative perfused tumour area to 0 .7± 0 .3% ; the 
perfusion fraction (PF) in these tum ours was homogeneous 
throughout the whole tumour. Previous studies had 
demonstrated that Photofrin-mediated PD T with 
200 J c n r -1 resulted in a tum our regrowth time (to 2 m m  
larger than treatment size) of 16.0 +  0.9 days compared to 
2 .8 +  0.1 days for untreated controls; no  cures were found 
with this light dose (van Geel et al., 1995a,/?). Tum ours 
treated with PD T at lower light doses (3 0 -6 0  J c m “ 1) also 
had reduced RPTA, which was most evident in the central 
parts  of the tumour (Figure 2b). After these lower light doses 
the tumours all regrew in less than 8 days (van Geel et a l., 
1995/;).
PD T caused a dose-dependent reduction in tum our 
perfusion (Figure 3), as assessed by image analysis. The P F  
of the RIF-1 tum our decreased significantly from 34.5 +  9.7% 
in untreated tumours to 10.8 +  2.5% at 5 min after 
2 0 0 J c m '" ,. These vascular perfusion data  showed a good 
linear correlation ( / =  0.98) with tum our perfusion previously 
estimated by the 86Rb extraction technique (van Geel et a l. , 
1994) (Figure 4).
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'Fable I Vascular and hypoxic parameters o f  the RUM tumour
» I « .
Treatment Tumour RVA {% ) RPTA t "») VF { %) RHA (";>)
U »treated control c 8.5:13.4 2.8 *0 .8 35.0:1:7.0 .1.6 :HM)l
P 12.2 .13» 3.9:1: LI 34,2:1:14.9 3.5 t {).4
t 9.4 l 4.1 3.0:1: Li 34.5 :b 9.7 3.5 ± 0.2
Photofrin alone (10 mg kg l) e 5.9:1: 1,0 2.1 ±  0.2 35.3 ±8 .8 3.2-1 1.1
P 6.8 1: 0.1 2.3:1: 0.4 35.4:1:9.6 2.1 :;t: 0.6
t 6.3 ± 0.5 2.2 i 0,3 36.6:1: K,4 2.5 i- 0.7
Light alone (200 J cm ’) c 3.9:1:0.4 0.7:1: 0.6 20.8:1: 17.1 3.0:1: 1,4
P 7.4 ± 2 .4 2.3 :fc 1.0 30.2:1:4.1 5.3 1 3.4
Piloto fri n-PDT (200 J cm ’)
t 5.6 :1: 1 ,4 1.5 ±  0.2 25.5 :!- 6.5 4.5:1: 2.8
c 6.3 .1:3.5 0.5-h 0.4 8.3 :fc 1.6 45.1:1- 1.5
P 6.6 i 0.7 0.9 ±  0.3 13.2 1-3.4 53.9 1:2.5
I 6.4:1 2.1 0.7 1 0.3 10.8:1:2.5" 51.0 1:2.1“
» I T  «  ftp W W W » * »  * *  ^  «
RVA, relative vascular area; RPTA, relative perfused total area; P l \  perfusion Fraction; RHA, relalive hypoxic area; c, central part o f  the tumour; 
p, peripheral tumour; t, centre l- periphery. “The whole-tumour data dilVcr significantly (7J<0.()5) From the untreated control ¿roup. Values are 
mean ¿-s.c. of 2 4 mice per group; three sections tor each region o f  the tumours.
a
• >  ¡- .
V — 'V: J ■} V , f
. ■> \ ?» 
/  ’> ,
I . :  * V  U
>  - . y  ' *  ’ ' Ì ,
-r > • •
: V ^  ■< '
; - . ' V
' S i  • ' /  ' '
t-r. ^  '• J  1 4 '  -,
" ■ . . . .  ..;•■■ ■*
, : : :  ’ ■> ■ ’  ' ' , v  <
-U r*- ro. ,  r; : v> ?
.> .*> v ; ' r  . '!■ - f -  
M X  '5>.
- a * ;
• < -1 ■
. ’i«'V:*v’'• • •'. j-. i ' - s . - V T . , * , ; - v > . . r y  1 - "  '>">
' * > . / • >  '  > - y > - ' r  k,  S  . '■
,  t  f- ' • ! - ' ^  ={
- ' I j u: ■ ;;  f ;  -1 : ' v >'■■ -, • •■ > s  • ,• i n -i •} '’ ■■■ ■■ ■ : • ■■•.■< ,'■:■■ ' ••
;  '' -J. > 4 ■ ■ 'i ■’  ■'! '  V'  ■
. 1 I ■ V'
,■> ^  >, ' * -
. . 1  ^ '1 J  .. V  ‘
• . .  i  . t “ '  ' * 4
• */ • : r- . '
■ » ; i ) .  v s -  ■•.
u < *  &  K .  K ■ '  ^ S > ’ ’ »V. ’ < ! v "-  h
• • i  >y
C' > 'rrJ • , ' "  v
• , v  > k  >  m > • '  r -
r \  '■ r.»•< «I ’ ; s *
s n  •-
i  V.< I . , ^
• P ^ (< ' y . r '
V  '  •/
■■ 1 . 1 - -   ^ V? /  ’ v„ " " • vVa " ì: . ,^.  : ^ - ,  .;v v' 4
, '■ . ■- •" v : . i ■
■ S ’ - ■■ *■ ■ .-■ ■ >  . p .  -■ • ’" ,,,*.) , -r ' s '■ • 'if . ,j.;
. • / ' >  > ' >  • '■> ,  ■' r,- ■-<• '•  o - r
• ■ . < •. '  ..............  • *
; , , - i; ? a  v. ,, ^ ' %  . /■ ’ ■* .
'  ' : ' ■- : S • :> *' r. ' •  ' ., 1 V ’ l 'AxJ ^
<>'• ’ ’•*1 » r* .1 * i, '<'*> ’’ ' >  . * '\ty. i • > o \  • ... r.;, . v , .. * , f>
?» ì • * v <, > . .  *. « . . , , ,  f  '  1 %  ^ . 'a, ■ • > i  ' 0
>■ r  v/" '
-  -1 V ' -  t ■■■-. , .  ' : . v
i- ■ '  },l>' ; N
■> "  '  > »
o ’. r  ,  ■>
\>  - ir,v  ä
.r > :’ i
^ ■ > ß (  ‘ A ' ■ ' 'Z .  ■> 
’  ; ' h.  ■ = ■ ■ / •
V x  T' '
/  . 'r -*>. r ^
V -  ■ 1 . : -,. < ' ■ I ► 1 .
f t  . .  1 '• '  v  >• ►
r’ A'  f
■ V - K  '
■ ■ • • v - f  ■
^  >•’ /  , 1  ’*> ' h r *j ;  , j  ?  * s  
-  V v  .= , j .
;  : •  S ,  r , .  -
'  - )<■■ • 
- v
: i  ■>'■:■
. ■■ f ;  ' >
1 , .  i 
*S5«
’ .  •‘¡ s
' '  y  -I n/,-.
>  » c  .  ^ '  C  ... .■": : i  '- s  :• •• • = .:, • •• ,  ••
* *  •>': I " r . >. •>. , , \ . s ■ / ?  J  '<# / j  • , f n * "* I “ .'.
•  *  ^v;/ > •? ' <■.... '
' - . ¿ v -  i) i ?(, l[ \ 1 mm
b
vQ
C
o
'Ü)Z3
tQia.
50 ~
40
30 -
20 -
10 -
0
0 50 100 150
Light d o se  (J cm"1)
50
40
30
-  20
10
0
200
v O
0 s
r a
’x
o
a
Figure 3 Effect o f  I’DT on the vascular perfusion ( 9 )  and 
hypoxia (O) o f  a 5 mm diameter RIT-I tumour 5min after 
illumination with different light doses given at 24 h after 
10 mg kg 1 PhotolVin as determined with image analysis. Control 
values (shown at OJcm'“1 light dose) represent untreated tumour 
perfusion. Values arc m eans±s,e. o f  2 4  mice per group.
Figure 2 Vascular perfusion in a 5 mm RIF-1 tumour. The vessel 
area is shown in red and the perfused tumour area in blue for (a) 
control tumour (b) experimental tumour (30 Jem"'1). The overlap 
of the vessel and perfused tumour area is shown in pink; this 
indicates the vessels that were perfused.
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after PI) . , ... , , ..
et af.s 1994). The correlation coefficient between the two 
techniques is 0.9H.
Hypoxic arcus
T h e  relaLive hypoxic area (RHA) (acute and  chronic), 
including the necrotic areas was quantified by image 
analysis. Alkaline phosphatase visualisation of the theophyl­
line tag in frozen sections of the control tum ours showed a 
very low background staining of unbound metabolites o f  
N IT P  (Figure 5a; Table I). The RHA in a 5 m m  untreated 
RIF-1 tumour was 3 .5± 0 .2% . No significant difference was
found between the control groups but PD T clearly increased 
the hypoxic fraction (Figure 5b; Table I). There was a light 
dosc-dependent increase in hypoxic areas at 5 min after PDT, 
with a corresponding dose-re la ted decrease in vascular 
perfusion (Figure 3). Superimposed images of adjacent 
tu m o u r  sections stained for hypoxic and perfused areas 
dem onstrated  that there was no overlap (Figure 5),
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Kigurc 5 Perfused and hypoxic areas in a 5mm RIF-1 tumour. 
Again the perfused vessels are given in blue and the hypoxic areas 
in (pseudoeolour) green for (a) control tumour (b) experimental 
tumour (30 J cm "').
Discussion
This study indicates tha t subcurative interstitial P D T  doses 
markedly decreased vascular perfusion in the centre and 
perip hery o f the R I F - 1 Ui mou r . Fo r the Iowcr light doses thi s 
decrease was more pronounced in the centre o f  the tum our 
close to the light source, Decreased perfusion resulted in a 
ight dose-re la ted increase in hypoxic areas, especially in the 
central part o f  the tumour.
There arc still problems associated with estimating the 
oxygenation status o f  individual tumours and their hypoxic 
fractions, e.g, invasive ness o f  the technique or large 
variability o f  signals measured in tumours from different 
animals. Correlations between results o f  two or more assays, 
as presented in this study, lend weight to the conclusions 
derived from such studies,
PDT-media ted cell kill with drugs such as Photofrin 
requires the presence o f  molecular oxygen and therefore an 
intact blood flow. Several studies with animal tumours 
(Henderson et a l 1985; Star et ctL,  1986; C hapm an  et al. ,  
1991/)) suggest that vascular elements are the most sensitive 
targets to P D T  and that secondary tum our cell death is 
induced by vascular shutdown. Most o f  these studies have 
focused on determination o f  total tum our blood flow and less 
attention has been paid to quantitative visualisation and 
localisation of functional perfusion and hypoxic areas 
simultaneously.
It is possible to detect functional tum our perfusion using 
the vascular m arker  Hoechst 33342. One possible d isadvan­
tage of this m ethod is tha t a high concentration o f  Hoechst 
has vasoactive properties in the RIF-1 tum our (van Geel,
unpublished results) and in the murine SCCVil tumour 
(Trotter et a/., 1990). For this study we used Hoechst in a 
fairly high concentration o f  30 mg kg '. Pilot studies 
indicated that this concentration provides sufficient fluores- 
ccnce intensity in tumour tissue sections to allow accurate 
counting using the image analysis system as used in this 
study. Hoechst is unlikely to have had a worked influence on 
the results of this image analysis study, however, since 
animals were sacrificed within 1 min o f  administration. 
Chaplin and Acker (1987) have previously demonstrated 
that mean tum our cell fluorescence increased linearly as a 
function of injected dose o f  Hoechst ( 3 - 3 0  mg kg~'), 
indicating that large doses of Hoechst, although vasoactive, 
do not cause immediate decreases in blood flow and staining. 
The good correlation we saw between tumour perfusion 
estimated from the image analysis of perfused vessels stained 
by Hoechst and w’Rb extraction (separate studies) also 
suggests that Hoechst-induced vasoconstriction was not a 
serious problem in these studies.
In our study the mean relative vascular area was 
approximately homogeneously distributed in a 5 mm un­
treated RIF-1 tumour. However, the data on tumour 
perfusion indicate that the number o f  vessels per unit area 
is not the only determining factor for tissue perfusion, since 
many vessels may not be functional. It is not clear whether 
the vessels in non-perfused areas identified in our studies were 
permanently or temporarily non functional.
Untreated RIF-1 tumours (5 mm) are free of evident 
necrosis and anti-theophylline staining revealed a low ( < 4 % )  
level of hypoxia. The precision with which NITP detects 
small proportions of cells with intermediate levels of oxygen 
is limited by non-specific background staining. When N ITP is 
injected before illumination (as in the experiments reported 
here), chronic and acute hypoxic regions are stained. The 
necrotic areas lack the ability to metabolise NITP. If NITP is 
given after illumination, drug access is likely to be inhibited 
for high light doses (> 1 0 0  J c m “ 1), which cause a rapid and 
pronounced decrease in perfusion (van Geel et a l ,  1994). 
Separate studies (data not shown) confirmed that this was, 
indeed, the case, since N ITP  given immediately after 
illumination only resulted in hypoxic staining after low light 
doses. Protocols giving N ITP before illumination are 
therefore much more suitable for estimating treatment- 
induced changes in hypoxic fraction. The data presented 
here indicate that N IT P  is metabolised in PDT-treated 
tumours at levels significantly higher than those measured 
in untreated control tumours. A 15-fold increase of 
metabolised drug was observed after P D T  compared with 
the untreated controls, M oore et a l  (1993) only found a 1.5- 
fold increase in hypoxic areas, detected with ,23I-labelled 
iodoazomycin arabinoside (IAZA, a nitroimidazole) in the rat 
Dunning R3327 AR tumours after PD T, This difference can 
probably be explained by the fact that the spontaneous 
hypoxic fraction of this rat tum our is quite variable, with 
mean values of 1 5"2 5% . It would therefore be difficult to 
demonstrate very large increases in hypoxic fraction after 
treatment. It is also possible that IAZA requires even lower 
oxygen concentrations for its metabolism than does NITP, or 
that the severity of PDT-induced hypoxia in the rat Dunning 
tum our was less than in the RIF-1 tumour.
Occasionally, immunohistochemical staining of hypoxic 
tum our areas was seen adjacent to the blood vessels. This 
may represent an example of acute hypoxia in which the 
blood flow has become temporarily disrupted at a time when 
the drug was available in the tum our cells for bioreductive 
metabolism. The duration o f  hypoxia was not measured in 
this study, however previous experiments indicated that 
blood flow was decreased for at least 24 h after PD T (van 
Geel et a l ,  1994). The K  value for radiobiological hypoxia is 
0 .4 -0 .5 %  (Begg et a l ,  1985; Hall, 1994). The dependence of  
N IT P  metabolism on oxygen concentration is similar to 
radiosensitivity, with a slightly lower K  value of approxi­
mately 0.1% (Hodgkiss et a l ,  1991). This indicates that the 
oxygen concentration in the tum our cells stained for bound 
metabolites of N ITP  after P D T  will probably be < 0 .1% . The
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degree of hypoxia required for bio reduction of N IT P  in the 
tumour after PD T  is similar to that required for other 
bio reductive drugs. It is known that bio red action o f  drugs 
such as SR4233 and mitomycin C is strongly dependent on 
oxygen levels with K  values of approximately 5% or 0.05% 
respectively (Marshall and Rauth, 1986; Koch, 1993). Thus, 
PDT should decrease the oxygen concentration in the tum our 
to below these levels to get an optimal effect from the 
combination of PD T and bio reductive drugs.
The image analysis study reported here visualised and 
quantified a significant decrease in vascular perfusion after 
PDT with a concomitant increase in hypoxic areas in the
RIF-1 tumour. These results lend support to the proposals 
for the combined use of P D T  and bio reductive drugs to 
exploit the PDT-indueed hypoxia.
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